Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Indegene share price prediction, Indegene share Price BSE, Indegene share price history, Indegene share Price screener, Indegene IPO share price, Indegene share price target 2026, and much more. Furthermore, this page provides details on Indegene‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Indegene Company Information
| Industry | Pharmaceutical consultancy |
| Founded | 1998; 28 years ago |
| Founder | Manish Gupta Sanjay Parikh Anand Kiran Gaurav Kapoor |
| Headquarters | Bangalore, India |
| Number of employees | 4,158 (2025) |
| Subsidiary | Indegene Ireland Limited |
Indegene Share Price Target Overview
- Current Price – 512.90
- Open – 523.45
- High – 535.00
- Low – 508.10
- Mkt cap – 12.36KCr
- P/E ratio – 30.86
- 52-wk high – 632.90
- 52-wk low – 414.00
- Dividend – N/A
- Qtrly div amt – N/A
Indegene Share Price Chart
Indegene Share Price Target Tomorrow (Prediction)
| Indegene Share Price Target Years | Indegene Share Price Target |
| 2026 | ₹650 |
| 2027 | ₹770 |
| 2028 | ₹890 |
| 2029 | ₹1020 |
| 2030 | ₹1150 |
Indegene Share Price Target 2026
The target for Indegene’s share price in 2026 is projected to range between ₹630 and ₹650. As of the end of May 2026, Indegene’s share price stood at ₹512.90. Compared to the previous year, Indegene’s share price has witnessed an decrease this year.
Indegene Share Price Target 2027
The target for Indegene’s share price in 2027 is projected to range between ₹750 and ₹770. On 30 May 2026, Indegene Share price NSE is 512.90 INR. Compared to last year, no significant difference has been observed in the share price of Indegene. The share price has decreased by approximately 90-100 rupees.
Indegene Share Price Target 2030
The target for Indegene’s share price in 2030 is projected to range between ₹1130 and ₹1150. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Zydus Lifesciences Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Indegene Shareholding Pattern
| Promoter | 0% |
| FII | 43.88% |
| DII | 3.60% |
| Retails & Others | 47.42% |
| Mutual Funds | 4.70% |
Income Statement Of Indegene
|
All values in INR
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
Mar 2026
|
|---|---|---|---|---|
|
Revenue
|
7.61B
|
8.04B
|
9.42B
|
10.03B
|
|
Cost of goods sold
|
–
|
–
|
–
|
–
|
|
Cost of revenue
|
–
|
–
|
–
|
–
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
4.82B
|
5.16B
|
5.68B
|
6.32B
|
|
Operating expense
|
6.27B
|
6.87B
|
8.22B
|
8.82B
|
|
Total operating expenses
|
6.27B
|
6.87B
|
8.22B
|
8.82B
|
|
Operating income
|
1.34B
|
1.17B
|
1.20B
|
1.22B
|
|
Other non operating income
|
221.00M
|
197.00M
|
194.00M
|
108.00M
|
|
EBT including unusual items
|
1.52B
|
1.33B
|
1.35B
|
1.05B
|
|
EBT excluding unusual items
|
1.52B
|
1.33B
|
1.35B
|
1.25B
|
|
Income tax expense
|
357.00M
|
310.00M
|
318.00M
|
254.00M
|
|
Effective tax rate
|
23.47%
|
23.29%
|
23.61%
|
24.17%
|
|
Other operating expenses
|
1.24B
|
1.48B
|
2.15B
|
2.07B
|
|
Net income
|
1.16B
|
1.02B
|
1.03B
|
797.00M
|
|
Net profit margin
|
15.30%
|
12.70%
|
10.92%
|
7.94%
|
|
Earnings per share
|
4.82
|
4.23
|
4.26
|
3.94
|
|
Interest and investment income
|
–
|
–
|
–
|
–
|
|
Interest expense
|
-37.00M
|
-38.00M
|
-46.00M
|
-72.00M
|
|
Net interest expenses
|
-37.00M
|
-38.00M
|
-46.00M
|
-72.00M
|
|
Depreciation and amortization charges
|
216.00M
|
234.00M
|
396.00M
|
418.00M
|
|
EBITDA
|
1.47B
|
1.40B
|
1.33B
|
1.53B
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- Shadowfax Technologies Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.